About ASP Isotopes
ASP Isotopes is a publicly listed company based in Boca Raton (United States) founded in 2021 by Robert Ainscow and Paul E Mann. Supply chain solution services for isotope production are provided. The company has 136 employees. ASP Isotopes has completed 1 acquisition, including Renergen. Its chief executive, as recorded, is Paul E Mann. Its website aspisotopes.com draws about 29 thousand monthly visits. ASP Isotopes offers products and services including Aerodynamic Separation Process, Quantum Enrichment, and Enriched Isotopes. Its focus areas include Biopharma Outsourcing and Logistics & Supply Chain. Its legal entity is ASP ISOTOPES INC. Its competitors include McKesson, Resilience and PAR Excellence; 1 of its 3 listed competitors has raised funding.
Company details
ASP Isotopes was founded in 2021 in Boca Raton, United States, by co-founders Robert Ainscow and Paul E. Mann, with Mann serving as CEO. Operations are centered on supply chain solutions within the advanced materials sector, particularly for isotopes used in medical, nuclear, and research applications. Services include sourcing, processing, and distribution to ensure reliable global availability. The company maintains a focus on development-stage initiatives to support industry needs.
- Headquarters Boca Raton, United States
- Employees 136
- Founders Robert Ainscow, Paul E Mann
- Stage Public
- SectorsHealthcare
- Website category Finance · Investing
- Website aspisotopes.com
- Social LinkedIn
- Legal Name Asp Isotopes Inc.
- Annual Revenue$23.85 M (USD)475.48as on Dec 31, 2025
- Net Profit-$175.09 M (USD)-441.52as on Dec 31, 2025
- EBITDA-$55.28 M (USD)-113.58as on Dec 31, 2025
- Latest Funding Round$109.18M (USD), Post-IPO
Jul 2026
- Employee Count136
- Investments & Acquisitions
Products & Services of ASP Isotopes
ASP Isotopes offers a comprehensive portfolio of products and services, including Aerodynamic Separation Process, Quantum Enrichment, and Enriched Isotopes.
Utilizes gaseous diffusion to separate isotopes for industrial use.
Employs lasers to efficiently separate isotopes based on atomic properties.
Provides customized enriched isotopes for medical and energy applications.
Funding Insights of ASP Isotopes
- Total Rounds 3
- Last Round Post-IPO — $109.18M
- First Round $5M
(Mar 2023)
All 3 funding rounds of ASP Isotopes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | $109.18M | Post-IPO | – | – | – |
| Oct 2023 | Post-IPO | – | – | – | |
| Mar 2023 | $5M | Post-IPO | – | – | – |
People of ASP Isotopes
4 people are tracked at ASP Isotopes (3 in leadership, 1 in team); the tracked headcount is 136.
| Name | Role | Group |
|---|---|---|
Robert Ainscow | Co-Founder | Leadership |
Paul E Mann | Co-Founder & CEO | Leadership |
Gerdus Kemp | Medical Director, CEO Of PET Labs | Leadership |
Simphiwe Ndlangamandla | Scientist | Team |
Complete people profiles for ASP Isotopes
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ASP Isotopes
ASP Isotopes is a publicly listed company on the NASDAQ with ticker symbol ASPI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Aug 2025
- Listed onJSE: ISO
- Listed entityASP Isotopes Inc.
- Exchange sectorHealth technology
- ISINUS00218A1051
- Share price$2.28 (-6.56% on the day) · 2026-10-13
- Market capitalisation$349.5M
- EPS (diluted, trailing year)$-1.32
- Volume (last session)5,020,666
Financials of ASP Isotopes
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $23.9M | -$175.1M | -$55.3M |
| 2024 | $4.1M | -$32.3M | -$25.9M |
| 2023 | $433,030 | -$16.3M | -$16.0M |
| 2022 | -$5.0M | -$5.0M | |
| 2021 | -$2.6M | -$2.6M |
Detailed financial statements for ASP Isotopes
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ASP Isotopes
ASP Isotopes has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Renergen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Natural gas and renewable energy investment firm | renergen.co.za | Johannesburg, South Africa | 2014 | Jan 2026 | •••• |
Complete acquisition details for ASP Isotopes
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ASP Isotopes
5 dated milestones of ASP Isotopes across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ASP Isotopes is founded.
- Funding First funding round of $5.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Renergen.
- Funding Latest funding round, Post-IPO, of $109.2M.
Competitors of ASP Isotopes
ASP Isotopes has 3 listed competitors in our database, 1 of them funded. They include McKesson, Resilience and PAR Excellence.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mckesson.com | 1833 | Irving, United States | 51,000 | Products and services are provided in the healthcare industry. | ||
| resilience.com | 1995 | San Diego, United States | $1.99B | Supply chain services for biopharma sector are provided. | ||
| parexcellence.com | 1997 | Cincinnati, United States | Supply chain logistics services are provided for the biopharma sector. |
Detailed competitors of ASP Isotopes
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ASP Isotopes
The website of ASP Isotopes (aspisotopes.com) receives about 28.6K visits a month and ranks #1,111,028 among all websites worldwide, #9,808 in Investing.
- Monthly visits28.6K
▲ 16% vs previous month
- Unique visitors10.5K
per month
- Global rank#1,111,028
among all websites
- Category rank#9,808
Finance · Investing
- Bounce rate38%
- Pages per visit1.9
- Average visit28 sec
- DevicesDesktop 43% · Mobile 57%
Websites whose visitors overlap most with ASP Isotopes. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| barchart.com | 100% | 9.2M | #5,766 | View details | |
| smallcaps.com.au | 91% | 133K | #322,015 | View details | |
| investorplace.com | 79% | 2M | #25,774 | View details | |
| moneyweb.co.za | 36% | 3M | #28,492 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ASP Isotopes (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Asp Isotopes
Complete news archive for ASP Isotopes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ASP Isotopes
ASP Isotopes was founded in 2021 and raised its 1st funding round 2 years after it was founded.
ASP Isotopes is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Paul E Mann is the CEO of ASP Isotopes, as recorded in our data. They have also founded this company.
ASP Isotopes has 136 employees.
Annual revenue of ASP Isotopes is $23.85M as on Dec 31, 2025.
ASP Isotopes was founded in 2021 in Boca Raton, United States, by co-founders Robert Ainscow and Paul E. Mann, with Mann serving as CEO. Operations are centered on supply chain solutions within the advanced materials sector, particularly for isotopes used in medical, nuclear, and research applications. Services include sourcing, processing, and distribution to ensure reliable global availability. The company maintains a focus on development-stage initiatives to support industry needs.
ASP Isotopes's top competitors include McKesson, Resilience and PAR Excellence.
ASP Isotopes offers Aerodynamic Separation Process, Quantum Enrichment, and Enriched Isotopes.
Yes, ASP Isotopes is publicly traded on NASDAQ under the ticker symbol ASPI.
ASP Isotopes has made 1 acquisition, including Renergen.
ASP Isotopes operates through Asp Isotopes Inc..